MedTrace Logo

Vfend Special Investigation For Pediatric - Observational

NCT02554656 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2021-04-14

Study results available
· View outcomes & findings →

Summary

Examine the safety and effectiveness of Vfend \[voriconazole\] for pediatric under general clinical practices.

Conditions

  • Pediatric Safety and Effectiveness

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
0 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-27
Primary Completion
2018-09-25
Completion
2018-09-25

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02554656 on ClinicalTrials.gov